BBIOBRIDGEBIO PHARMA INC
CUSIP 10806X102 · common stock · Other share classes: 10806XAB8, 10806XAD4, 10806XAJ1
7 tracked investors held BRIDGEBIO PHARMA INC (BBIO) at the end of Q3 2026, worth $819.2M in total. The largest holder was Andreas Halvorsen, with 2.0% of its portfolio. Joel Greenblatt opened a new position this quarter.
Holders · Q3 2026
7
New holders
1
Value held
$819.2M
Quarter-end price (est.)
$65.80
Investors holding BBIO · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Andreas Halvorsen Viking Global Investors LP | 1.97% | 9,792,219 | $644.3M | REDUCE-1.6% |
| PRIMECAP Management PRIMECAP Management Co | 0.07% | 1,699,422 | $111.8M | ADD+67.3% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 1.06% | 379,261 | $25M | ADD+114.6% |
| Ken Fisher Fisher Asset Management, LLC | 0.01% | 348,675 | $22.9M | ADD+1.0% |
| Chuck Royce Royce & Associates LP | 0.13% | 218,487 | $14.4M | HOLD |
| Joel Greenblatt Gotham Asset Management, LLC | 0.00% | 6,949 | $457.2K | NEW |
| Polen Capital Management Polen Capital Management LLC | 0.00% | 4,510 | $296.8K | ADD+12.7% |